相关实验视频
Updated: Jul 15, 2025

08:07
Three-Dimensional Bone Extracellular Matrix Model for Osteosarcoma
Published on: April 12, 2019
7.2K
(E) - SIS3通过促进细胞亡,阻止细胞循环和调节瘤免疫微环境来抑制骨髓瘤的进展
Zhen Huang1, Chunlin Zhang1, Kunpeng Zhu1
1Department of Orthopaedic, Shanghai Tenth People's Hospital, School of Medicine, Tongji University, Shanghai, China.
Drug development research
|October 3, 2023
概括
母亲对抗去角性同源3 (Smad3) 通过影响瘤免疫微环境,驱动骨髓瘤的进展. 抑制Smad3抑制了瘤生长,扩散和转移,这表明它是骨髓瘤的潜在治疗标.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 骨髓瘤是一种常见的骨癌,预后不佳.
- 母亲对抗十足的同源3 (Smad3) 是一个潜在的治疗点,但其在骨髓瘤中的作用尚不清楚.
研究的目的:
- 研究Smad3在骨髓瘤进展中的作用.
- 探索Smad3作为骨髓瘤的潜在治疗点.
主要方法:
- 使用了生物信息学分析,Western Blot,细胞增殖试验 (殖民地形成,CCK-8),迁移/入侵试验 (Transwell,伤口愈合),流细胞计和异种移植瘤模型.
- 分析了Smad3表达及其对体外和体内骨髓瘤细胞的影响.
主要成果:
- 在骨髓瘤细胞中,Smad3蛋白过度表达.
- 抑制Smad3减少了增殖,迁移和入侵,诱导了细胞灭绝,阻止了细胞循环,抑制了瘤生长.
- 高Smad3表达与骨髓瘤中免疫状况不佳相关.
结论:
- 通过调节瘤免疫微环境,Smad3促进骨髓瘤的进展.
- 在骨髓瘤治疗中,Smad3 是一个有前途的治疗标.
更多相关视频
11:15A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells
Published on: May 6, 2018
10.3K
07:31A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate
Published on: May 3, 2021
3.7K
相关概念视频
Mesenchymal Stem Cells
4.8K
Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their...
4.8K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K